Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

From AI Chat GPT Yes, leronlimab (also known

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155494
(Total Views: 581)
Posted On: 12/01/2024 6:08:47 AM
Posted By: biloxiblues
Re: chazzledazzle #148365

From AI Chat GPT

Yes, leronlimab (also known as PRO 140) is a monoclonal antibody primarily developed to target CCR5 (C-C chemokine receptor type 5), which plays a key role in immune system signaling, particularly in the recruitment of immune cells like macrophages, T-cells, and other leukocytes. CCR5 is involved in inflammatory and immune responses, and blocking it with leronlimab can impact these processes.

Regarding its inflammatory effects due to macrophage shift, the relationship is more nuanced:

Macrophage polarization: Macrophages can polarize into different functional states, such as M1 (pro-inflammatory) and M2 (anti-inflammatory). The shift of macrophages between these states can influence the level of inflammation in the body. By blocking CCR5, leronlimab can affect the recruitment and polarization of macrophages. Some studies suggest that inhibiting CCR5 may reduce inflammatory macrophage activation in certain contexts, but it might also lead to shifts in macrophage function, either enhancing or dampening inflammation depending on the specific disease context.

Potential Inflammatory Effects: Leronlimab's inhibition of CCR5 has been explored for conditions such as HIV, cancer, and autoimmune diseases, where the modulation of macrophage function and inflammatory responses could be beneficial or potentially harmful. In some cases, manipulating macrophage function can influence the disease outcome—both beneficially and negatively—depending on whether the inflammatory response is appropriately controlled.

Immune modulation: Leronlimab has been shown to modulate the immune system, possibly reducing excessive inflammation in certain diseases, but in other cases, it could lead to a shift in immune responses that might exacerbate inflammation, depending on the balance of immune signaling.

Therefore, while leronlimab's effects on macrophages and inflammation are being studied, its overall inflammatory impact due to macrophage shift would depend on the specific disease and context in which it's used. It may reduce or modulate inflammatory responses, but further research is required to fully understand its effects across different conditions.





(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us